Drugs / Kindolor
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06243835 | Apr → Nov 2024 | chronic pain syndrome | Lohocla Research Corporation | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kindolor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06243835 ↗ |
| Known as | Kindolor Tosylate | “Kindolor Tosylate enteric coated tablets containing the specified amount of drug product” NCT06243835 ↗ |